MULTIPLE-SCLEROSIS - CHANGING TIMES

被引:31
|
作者
KURTZKE, JF [1 ]
机构
[1] VET AFFAIRS MED CTR,NEUROL SERV,WASHINGTON,DC 20422
关键词
MULTIPLE SCLEROSIS; DISTRIBUTION; CHANGING INCIDENCE; EPIDEMICS; TYPE-I EPIDEMIC;
D O I
10.1159/000110240
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Multiple sclerosis (MS) is distributed about the world in three zones of high, medium, and low frequency. All high- and medium-risk areas are among predominantly white populations. Migration studies indicate MS is already acquired by age 15 in high-risk endemic areas and that low-to-high migrants increase their risk from age 11 years. Therefore MS is an environmental disease ordinarily acquired in adolescence with a long incubation before symptom onset. Susceptibility is limited to the period from about age 11 to 47. In general, MS death rates have been declining over time while prevalence rates have increased. Incidence rates have also increased, however, in: northeastern Scotland; Turku, Finland; Hordaland, Norway; Rochester, Minn.; Lower Saxony; several areas of Italy. Incidence was unchanged in northernmost Norway. Conversely, incidence and prevalence rates have decreased in the Shetland-Orkneys; there was a cyclical pattern in incidence in Rostock, GDR; and there was a transient doubling of incidence in Iceland in the post-World War II decade. In the Faroe Islands, MS was absent before 1943 when a major point-source epidemic began, reaching an incidence rate of 10 per 100,000 population in 1945. This was followed by two consecutively smaller epidemics with respective peaks each about 12 years later, and there is now a new epidemic IV on these islands. Explanations for changing incidence of MS over time should bring us closer to solving the etiology of this disease.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 50 条
  • [21] CONSANGUINITY AND MULTIPLE-SCLEROSIS IN ORKNEY
    ROBERTS, DF
    GENETIC EPIDEMIOLOGY, 1991, 8 (03) : 147 - 151
  • [22] CSF ANALYSIS IN MULTIPLE-SCLEROSIS
    SINDIC, CJM
    ACTA NEUROLOGICA BELGICA, 1994, 94 (02) : 103 - 111
  • [23] HLA AND PROGNOSIS IN MULTIPLE-SCLEROSIS
    RUNMARKER, B
    MARTINSSON, T
    WAHLSTROM, J
    ANDERSEN, O
    JOURNAL OF NEUROLOGY, 1994, 241 (06) : 385 - 390
  • [24] IMPLICIT MEMORY IN MULTIPLE-SCLEROSIS
    LATCHFORD, G
    MORLEY, S
    PEACE, K
    BOYD, J
    BEHAVIOURAL NEUROLOGY, 1993, 6 (03) : 129 - 133
  • [25] ACETYLATOR POLYMORPHISM IN MULTIPLE-SCLEROSIS
    LADERO, JM
    ARROYO, R
    DEANDRES, C
    JIMENEZJIMENEZ, FJ
    MOLINA, JA
    DESEIJAS, EV
    GIMENEZROLDAN, S
    BENITEZ, J
    ACTA NEUROLOGICA SCANDINAVICA, 1994, 89 (02): : 102 - 104
  • [26] ENDOCRINE FUNCTION IN MULTIPLE-SCLEROSIS
    KLAPPS, P
    SEYFERT, S
    FISCHER, T
    SCHERBAUM, WA
    ACTA NEUROLOGICA SCANDINAVICA, 1992, 85 (05): : 353 - 357
  • [27] GENES AND SUSCEPTIBILITY TO MULTIPLE-SCLEROSIS
    COMPSTON, DAS
    WOOD, HK
    ROBERTSON, N
    SAWCER, S
    WOOD, NW
    ACTA NEUROLOGICA SCANDINAVICA, 1995, 91 : 43 - 51
  • [28] ACHROMATOPSIA AS SYMPTOM OF MULTIPLE-SCLEROSIS
    MULLER, T
    BUTTNER, T
    KUHN, W
    PRZUNTEK, H
    NEURO-OPHTHALMOLOGY, 1994, 14 (05) : 277 - 278
  • [29] THE PATHOLOGICAL EVOLUTION OF MULTIPLE-SCLEROSIS
    MCDONALD, WI
    MILLER, DH
    BARNES, D
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1992, 18 (04) : 319 - 334
  • [30] MULTIPLE-SCLEROSIS IN ARABS IN JORDAN
    ALDIN, ASN
    ELKHATEEB, M
    KURDI, A
    MUBAIDIN, A
    WRIEKAT, A
    ALSHEHAB, A
    KHALIL, RW
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1995, 131 (02) : 144 - 149